(NASDAQ:LIXT),(NASDAQ:LIXTW), BOCA RATON, Fla., Oct. 29, 2025 (GLOBE NEWSWIRE) — LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT, LIXTW), a clinical-stage pharmaceutical company advancing LB-100, a first-in-class inhibitor of protein phosphatase 2A (PP2A), today announced that Geordan Pursglove, its chief executive officer, will present at the Spartan Capital Investor Conference 2025 in New […]

(NASDAQ:SIEB), MIAMI, NEW YORK and WASHINGTON, Oct. 29, 2025 (GLOBE NEWSWIRE) — Siebert Financial Corp. (NASDAQ: SIEB) today announced the opening of a Washington, D.C. office to support its expanding Capital Markets and Investment Banking team. Located at 3000 K Street, N.W., Suite 245, Washington, D.C., the new office will be led by Daniel M.

STONE RIDGE, N.Y., Oct. 29, 2025 (GLOBE NEWSWIRE) — HowGood, the leading sustainability intelligence platform for the food and beverage industry, today announced its conformance with the Partnership for Carbon Transparency (PACT) Technical Specifications. HowGood's unmatched Product Carbon Footprint (PCF) database immediately elevates and operationalizes PACT, effectively transforming the global standard into the food industry's

(NASDAQ:MLTX), ATLANTA, Oct. 29, 2025 (GLOBE NEWSWIRE) — A shareholder class action lawsuit has been filed against MoonLake Immunotherapeutics (“MoonLake” or the “Company”) (NASDAQ: MLTX). The lawsuit alleges that Defendants made materially false and/or misleading statements and/or failed to disclose material adverse information regarding the distinction between the Nanobodies and monoclonal antibodies, including that: (1)

(NASDAQ:LENZ), SAN DIEGO, Oct. 29, 2025 (GLOBE NEWSWIRE) — LENZ Therapeutics, Inc. (Nasdaq: LENZ or “LENZ” or the “Company”), a pharmaceutical company focused on the commercialization of VIZZ(TM) (aceclidine ophthalmologic solution) 1.44%, the first and only FDA-approved aceclidine-based eye drop for the treatment of presbyopia in adults, today announced that it will host a webcast

(NASDAQ:RDVT), BOCA RATON, Fla., Oct. 29, 2025 (GLOBE NEWSWIRE) — FOREWARN, LLC, a red violet company (NASDAQ: RDVT) and the leading provider of real-time information solutions for real estate agents, today announced that Salt Lake Board of REALTORS(R) will offer FOREWARN(R) services to its 9,000+ members it serves throughout Salt Lake City and the surrounding

MALVERN, Pa., Oct. 29, 2025 (GLOBE NEWSWIRE) — YPrime, a proven leader in clinical trial technology, today announced the launch of its Advanced eCOA Oversight functionality–a key enhancement to its eCOA platform designed to simplify and strengthen how Principal Investigators (PIs) review and acknowledge participant data. Recent updates from the EMA Guideline on Computerized Systems1

(NASDAQ:VRA), FORT WAYNE, Ind., Oct. 29, 2025 (GLOBE NEWSWIRE) — Vera Bradley, Inc. (“Vera Bradley” or the “Company”) (NASDAQ:VRA) today announced the appointment of Melinda Paraie as the Company's Chief Brand Officer effective November 1, 2025. “We are pleased that Melinda is joining the Company at this pivotal moment as we implement our comprehensive strategy

CHICAGO, Oct. 29, 2025 (GLOBE NEWSWIRE) — The Financial Health Network, the nation's leading authority on consumer financial health, today released its FinHealth Spend Report 2025, revealing that U.S. households spent an estimated $455 billion on interest and fees for financial services in 2024, marking a nearly $100 billion increase in just two years. The

(NASDAQ:RVPH), CUPERTINO, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) — Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), inflammatory and cardiometabolic diseases, today announced that Laxminarayan Bhat, Ph.D., Founder, President, and CEO of